Related Experiment Video
Updated: Aug 23, 2026
The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
Published on: December 19, 2025
Randomized clinical stroke trials in 2003
1Burke Rehabilitation Hospital and Medical Research Institute, Weill Medical College of Cornell University, 785 Mamaroneck Avenue, White Plains, NY 10605, USA. mrabadi@burke.org
Insights
Treating hypertension, hyperlipidemia, and atrial fibrillation reduces future strokes. However, female hormone therapy showed no benefit, while donepezil may help stroke-related dementia.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Clinical Trials
Background:
- Stroke remains a leading cause of long-term disability.
- Identifying effective interventions for stroke prevention and management is crucial.
- Understanding the impact of treating modifiable risk factors is essential for public health.
Purpose of the Study:
- To review randomized clinical trials published in 2003 focusing on stroke risk factor modification.
- To evaluate the efficacy of various treatments in reducing future stroke incidence.
- To assess the impact of interventions on post-stroke cognitive impairment.
Main Methods:
- Analysis of randomized clinical trials published in 2003.
- Review of studies investigating treatments for hypertension, hyperlipidemia, and atrial fibrillation.
- Evaluation of trials on hormone replacement therapy and donepezil for stroke patients.
Main Results:
- Treatments for hypertension, hyperlipidemia, and atrial fibrillation (using a new anticoagulant) demonstrated significant benefits in reducing future strokes.
- Female hormone therapy was found to be not beneficial for stroke prevention.
- Donepezil showed potential as a treatment for post-stroke dementia.
Conclusions:
- Aggressive management of hypertension, hyperlipidemia, and atrial fibrillation is key to stroke risk reduction.
- Female hormone therapy is not recommended for preventing strokes.
- Donepezil represents a promising therapeutic option for cognitive deficits following stroke.
Abstract:
Randomized clinical stroke trials published during 2003 dealt with what impact treatment of stroke risk factors have on reducing future strokes. Treatment of hypertension and hyperlipidemia, and atrial fibrillation with a new anticoagulant, were confirmed to be beneficial. Treatment with female hormones was not beneficial. A potentially important study indicated that donepezil is a useful treatment for dementia in people who have had strokes.
